MHT in cancer survivors
The decision of whether or not to use MHT after cancer is complex. It depends not only on indication (menopausal symptoms), but also on age and hormone dependence of the tumour. For example, squamous cell tumors of the cervix and vulva and hematological malignancies are not hormone dependent. However, breast tumours may express estrogen and progesterone receptors. Radiotherapy and chemotherapy can lead to premature ovarian failure, especially after cancer in childhood, leading to associated health consequences.
Source: Maturitas - Category: Primary Care Authors: Margaret Rees Tags: INV62 Source Type: research
More News: Cancer | Cancer & Oncology | Cervical Cancer | Chemotherapy | Childhood Cancer | Hematology | Hormones | Men | Menopause | Ovarian Cancer | Ovaries | Primary Care | Squamous Cell Carcinoma